With the Right Approach, Vulnerable Populations Can and Should be Engaged in Research

Blog

In clinical research settings, “vulnerable populations” refer to groups of people who can be harmed, manipulated, coerced, or deceived by unscrupulous researchers because of their limited decision-making ability, lack of power, or disadvantaged status. However, individuals from these populations may legitimately participate in clinical trials under ethical and well-managed conditions,

What to Do When “Doing More with Less” is Your Study Site’s New Directive

Blog

While the “do more with less” mantra probably dates back to some well-meaning prehistoric manager from the dawn of organized labor, its modern prevalence in clinical research settings can seem particularly galling in the face of serious fiscal uncertainties and ongoing workforce supply and readiness challenges when patients’ lives and wellbeing are on the line. 

Perspectives of Primary/Urgent Care Providers on Their Role in Supporting Clinical Trials

Clinical Researcher

This study surveyed primary/urgent care providers (PCPs) to identify facilitators and barriers to their support of clinical trial referrals. The findings suggest that increasing provider awareness, streamlining referral processes, and fostering a culture incorporating clinical research into routine patient care could enhance PCP support for clinical trials. Addressing these barriers is critical to improving recruitment efforts and advancing medical research.

Aligned for Impact: Strengthening Sponsor-CRO-Site Partnerships in Today’s Trials

Clinical Researcher

Clinical trials have become more complex, due to myriad factors including rising protocol demands, the adoption of decentralized models, and the integration of artificial intelligence. While these innovations promise greater personalization and operational efficiency, they also introduce new layers of logistical and regulatory complexity. Sponsors and CROs should collaborate to design site-centric processes that reduce operational burden, streamline communication, and allow research teams to focus more on patient care and data quality.

Investigating Insomnia: Closing the Gender Gap in Clinical Pharmacology

Clinical Researcher

Although researchers are required to consider sex as a biological variable, the field of sex-based biology and medicine remains underdeveloped and often mischaracterized as peripheral. This article investigates gender disparities in clinical trials and pharmacology, focusing on adverse drug reactions and highlighting critical areas where differences in drug tolerability between genders are most significant, particularly in the management of insomnia.